$336.88
Value $131B
ETN and MLAB stock compared: price, dividend, valuation and results, from SEC filings.
$336.88
Value $131B
$134.09
Value $741M
Eaton (ETN) has a market value of $131B and Mesa Laboratories (MLAB) $741M. Over the last year, with dividends, ETN moved -3.3% and MLAB +82.5%. The P/E is 33.5 for ETN and 111.2 for MLAB. Dividend yield: ETN 1.31%, MLAB 0.48%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
ETN$131B
MLAB$741M
ETN is 176 times MLAB
Revenue, 12 months
ETN$32.0B
MLAB$251M
ETN is 127 times MLAB
Net income, 12 months
ETN$3.9B
MLAB$6.7M
ETN is 585 times MLAB
Operating margin
ETN–
MLAB10.4%
ROIC
ETN10.8%
MLAB7.0%
3.7 points apart
P/E
ETN33.5
MLAB111.2
MLAB is 3.3 times ETN
Dividend yield
ETN1.3%
MLAB0.5%
0.8 points apart
5-year return
ETN+110.4%
MLAB-55.1%
165.5 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
ETN+110.4%
MLAB-55.1%
| Period | ETNWith dividends | MLABWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | -3.3%Price -4.4% | +82.5%Price +81.3% |
| 3 years since November 16, 2023 | +54.1%+15.5% a yearPrice +48.5% | +49.2%+14.3% a yearPrice +46.4% |
| 5 years since November 15, 2021 | +110.4%+16.0% a yearPrice +95.0% | -55.1%-14.8% a yearPrice -56.3% |
| 10 years since November 16, 2016 | +529.7%+20.2% a yearPrice +414.0% | +9.6%+0.9% a yearPrice +5.0% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
ETNEatonMLABMesa Laboratories
| Price | $336.88 | $134.09 |
|---|---|---|
| Market value | $131B | $741M |
| Enterprise value (EV) | $149B | – |
| P/E | 33.5 | 111.2 |
| P/E, 5-year median | 30.5 | – |
| P/B | 6.2 | 3.8 |
| EV/EBIT | 30.4 | – |
| Free cash flow yield | 2.9% | 6.7% |
| Revenue, 12 months | $32.0B | $251M |
|---|---|---|
| Net income, 12 months | $3.9B | $6.7M |
| Free cash flow, 12 months | $3.8B | $49M |
| Earnings per share, 12 months | $10.01 | $1.15 |
| Revenue growth, year on year | 10.3% | 3.4% |
| Revenue growth a year, past | +9.0%over 5 years | +13.2%over 5 years |
| EPS growth a year, past | +24.5%over 5 years | +13.6%over 5 years |
| Gross margin | 35.1% | 64.8% |
|---|---|---|
| Operating margin | – | 10.4% |
| Net margin | 12.2% | 2.7% |
| ROIC | 10.8% | 7.0% |
| ROE | 19.6% | 3.6% |
| Cash | $818M | $22M |
|---|---|---|
| Total debt | $20.2B | – |
| Net debt / EBITDA | 3.1 | – |
| Interest cover | 8.6× | 2.6× |
| Dividend yield | 1.3% | 0.5% |
|---|---|---|
| Dividend per share, 12 months | $4.40 | $0.64 |
| Dividend growth a year, past | +7.3%over 5 years | +0.0%over 5 years |
| Buyback yield | 1.4% | – |
| Shareholder yield | 2.7% | 0.5% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Eaton ($131B) is about 176.4 times Mesa Laboratories ($741M), at today's prices.
Since November 16, 2016, ETN's price moved +414.0% and MLAB's +5.0%. With dividends: ETN +529.7% (+20.2% a year), MLAB +9.6% (+0.9% a year). Past returns do not predict future ones.
The dividend yield at today's price is 1.31% for Eaton and 0.48% for Mesa Laboratories. Over the last twelve months they paid $4.40 and $0.64 per share.
At today's price, the P/E is 33.5 for ETN and 111.2 for MLAB. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 12.2% for Eaton and 2.7% for Mesa Laboratories, and the operating margin – and 10.4%. Revenue was $32.0B and $251M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.